Reconstructing targetable pathways in lung cancer by integrating diverse omics data-Reference-Cited by-同舟云学术

Reconstructing targetable pathways in lung cancer by integrating diverse omics data

Published:2013-10-18 Issue:1 Volume:4 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Balbin O. Alejandro,Prensner John R.,Sahu Anirban,Yocum Anastasia,Shankar Sunita,Malik Rohit,Fermin Damian,Dhanasekaran Saravana M.,Chandler Benjamin,Thomas Dafydd,Beer David G.,Cao Xuhong,Nesvizhskii Alexey I.,Chinnaiyan Arul M.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms3617.pdf

Reference67 articles.

1. Karnoub, A. & Weinberg, R. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9, 517–531 (2008).

2. Dogan, S. et al. Molecular epidemiology of EGFR and KRAS mutations in 3026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clin. Cancer Res. 18, 6169–6177 (2012).

3. Riely, G. J. et al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin. Cancer Res. 14, 5731–5734 (2008).

4. Society, A.C. American Cancer Society Figures and Facts (2012).

5. Barbie, D. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108–112 (2009).

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?;Lung Cancer;2024-08

2. Pneumococcal hydrogen peroxide regulates host cell kinase activity;Frontiers in Immunology;2024-06-05

3. In situ modeling of acquired resistance to RTK/RAS-pathway-targeted therapies;iScience;2024-01

4. SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status;Proceedings of the National Academy of Sciences;2023-11-16

5. Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma;ACS Omega;2023-07-17